Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa

Bharat Jasani, Fiona Campbell, Hossein Navabi, Kurt W. Schmid, Geraint T. Williams

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Metallothionein (MT) overexpression occurs frequently in human tumours but the underlying mechanism is unknown. Morphologically normal-appearing mucosa from human colorectal carcinoma resection specimens and of the colons of ageing laboratory mice contains scattered single crypts whose cells show uniformly increased MT immunostaining, suggesting that MT overexpression arises directly from random crypt stem cell somatic mutation, followed by colonization of the clonal unit by the mutated progeny. This hypothesis has now been tested by quantifying the frequency of immunocytochemically detectable monocryptal colorectal MT overexpression, 5 and 30 days after injection of 8-week-old mice with a single dose of the mutagen dimethylhydrazine (DMH, 30 mg/kg subcutaneous). Otherwise normal-appearing MT-positive crypts were recorded as either wholly or partially involved by the overexpressing phenotype. Five days after DMH injection, the median frequency of partially involved MT-positive crypts was 11.7 x 10-4, declining significantly to 1.8 x 10-4 at 30 days (Mann-Whitney U, P-4 at 5 days, increasing significantly (P-4 at 30 days. The frequency of MT-positive crypts and the time course of evolution of partially involved to wholly involved forms were similar to those described for mutation-induced crypt-restricted loss of glucose-6-phosphate dehydrogenase activity in mice treated with an identical DMH regimen. The findings indicate that cellular MT overexpression can occur as a direct consequence of somatic mutation, either cis-activating mutation(s) of the MT gene itself, or trans-activating mutation(s) of other genes involved in controlling MT expression. This is likely to be an important mechanism underlying MT overexpression in neoplasia. Such mutation-induced aberrant MT expression may be involved in the acquisition of selective cellular growth or survival advantage during tumour progression.

Original languageEnglish
Pages (from-to)144-147
Number of pages4
JournalJournal of Pathology
Volume184
Issue number2
DOIs
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Metallothionein
Mucous Membrane
Mutation
Dimenhydrinate
Dimethylhydrazines
Neoplasms
Injections
Adult Stem Cells
Glucosephosphate Dehydrogenase
Mutagens
Genes
Colorectal Neoplasms
Colon

Keywords

  • Clonality
  • Colon
  • Gene expression
  • Human
  • Metallothionein
  • Mouse
  • Mutation
  • Neoplasia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. / Jasani, Bharat; Campbell, Fiona; Navabi, Hossein; Schmid, Kurt W.; Williams, Geraint T.

In: Journal of Pathology, Vol. 184, No. 2, 1998, p. 144-147.

Research output: Contribution to journalArticle

Jasani, Bharat ; Campbell, Fiona ; Navabi, Hossein ; Schmid, Kurt W. ; Williams, Geraint T. / Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. In: Journal of Pathology. 1998 ; Vol. 184, No. 2. pp. 144-147.
@article{950ff585736f45dd902df22f251bde3d,
title = "Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa",
abstract = "Metallothionein (MT) overexpression occurs frequently in human tumours but the underlying mechanism is unknown. Morphologically normal-appearing mucosa from human colorectal carcinoma resection specimens and of the colons of ageing laboratory mice contains scattered single crypts whose cells show uniformly increased MT immunostaining, suggesting that MT overexpression arises directly from random crypt stem cell somatic mutation, followed by colonization of the clonal unit by the mutated progeny. This hypothesis has now been tested by quantifying the frequency of immunocytochemically detectable monocryptal colorectal MT overexpression, 5 and 30 days after injection of 8-week-old mice with a single dose of the mutagen dimethylhydrazine (DMH, 30 mg/kg subcutaneous). Otherwise normal-appearing MT-positive crypts were recorded as either wholly or partially involved by the overexpressing phenotype. Five days after DMH injection, the median frequency of partially involved MT-positive crypts was 11.7 x 10-4, declining significantly to 1.8 x 10-4 at 30 days (Mann-Whitney U, P-4 at 5 days, increasing significantly (P-4 at 30 days. The frequency of MT-positive crypts and the time course of evolution of partially involved to wholly involved forms were similar to those described for mutation-induced crypt-restricted loss of glucose-6-phosphate dehydrogenase activity in mice treated with an identical DMH regimen. The findings indicate that cellular MT overexpression can occur as a direct consequence of somatic mutation, either cis-activating mutation(s) of the MT gene itself, or trans-activating mutation(s) of other genes involved in controlling MT expression. This is likely to be an important mechanism underlying MT overexpression in neoplasia. Such mutation-induced aberrant MT expression may be involved in the acquisition of selective cellular growth or survival advantage during tumour progression.",
keywords = "Clonality, Colon, Gene expression, Human, Metallothionein, Mouse, Mutation, Neoplasia",
author = "Bharat Jasani and Fiona Campbell and Hossein Navabi and Schmid, {Kurt W.} and Williams, {Geraint T.}",
year = "1998",
doi = "10.1002/(SICI)1096-9896(199802)184:2<144::AID-PATH998>3.0.CO;2-J",
language = "English",
volume = "184",
pages = "144--147",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa

AU - Jasani, Bharat

AU - Campbell, Fiona

AU - Navabi, Hossein

AU - Schmid, Kurt W.

AU - Williams, Geraint T.

PY - 1998

Y1 - 1998

N2 - Metallothionein (MT) overexpression occurs frequently in human tumours but the underlying mechanism is unknown. Morphologically normal-appearing mucosa from human colorectal carcinoma resection specimens and of the colons of ageing laboratory mice contains scattered single crypts whose cells show uniformly increased MT immunostaining, suggesting that MT overexpression arises directly from random crypt stem cell somatic mutation, followed by colonization of the clonal unit by the mutated progeny. This hypothesis has now been tested by quantifying the frequency of immunocytochemically detectable monocryptal colorectal MT overexpression, 5 and 30 days after injection of 8-week-old mice with a single dose of the mutagen dimethylhydrazine (DMH, 30 mg/kg subcutaneous). Otherwise normal-appearing MT-positive crypts were recorded as either wholly or partially involved by the overexpressing phenotype. Five days after DMH injection, the median frequency of partially involved MT-positive crypts was 11.7 x 10-4, declining significantly to 1.8 x 10-4 at 30 days (Mann-Whitney U, P-4 at 5 days, increasing significantly (P-4 at 30 days. The frequency of MT-positive crypts and the time course of evolution of partially involved to wholly involved forms were similar to those described for mutation-induced crypt-restricted loss of glucose-6-phosphate dehydrogenase activity in mice treated with an identical DMH regimen. The findings indicate that cellular MT overexpression can occur as a direct consequence of somatic mutation, either cis-activating mutation(s) of the MT gene itself, or trans-activating mutation(s) of other genes involved in controlling MT expression. This is likely to be an important mechanism underlying MT overexpression in neoplasia. Such mutation-induced aberrant MT expression may be involved in the acquisition of selective cellular growth or survival advantage during tumour progression.

AB - Metallothionein (MT) overexpression occurs frequently in human tumours but the underlying mechanism is unknown. Morphologically normal-appearing mucosa from human colorectal carcinoma resection specimens and of the colons of ageing laboratory mice contains scattered single crypts whose cells show uniformly increased MT immunostaining, suggesting that MT overexpression arises directly from random crypt stem cell somatic mutation, followed by colonization of the clonal unit by the mutated progeny. This hypothesis has now been tested by quantifying the frequency of immunocytochemically detectable monocryptal colorectal MT overexpression, 5 and 30 days after injection of 8-week-old mice with a single dose of the mutagen dimethylhydrazine (DMH, 30 mg/kg subcutaneous). Otherwise normal-appearing MT-positive crypts were recorded as either wholly or partially involved by the overexpressing phenotype. Five days after DMH injection, the median frequency of partially involved MT-positive crypts was 11.7 x 10-4, declining significantly to 1.8 x 10-4 at 30 days (Mann-Whitney U, P-4 at 5 days, increasing significantly (P-4 at 30 days. The frequency of MT-positive crypts and the time course of evolution of partially involved to wholly involved forms were similar to those described for mutation-induced crypt-restricted loss of glucose-6-phosphate dehydrogenase activity in mice treated with an identical DMH regimen. The findings indicate that cellular MT overexpression can occur as a direct consequence of somatic mutation, either cis-activating mutation(s) of the MT gene itself, or trans-activating mutation(s) of other genes involved in controlling MT expression. This is likely to be an important mechanism underlying MT overexpression in neoplasia. Such mutation-induced aberrant MT expression may be involved in the acquisition of selective cellular growth or survival advantage during tumour progression.

KW - Clonality

KW - Colon

KW - Gene expression

KW - Human

KW - Metallothionein

KW - Mouse

KW - Mutation

KW - Neoplasia

UR - http://www.scopus.com/inward/record.url?scp=0031911745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031911745&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(199802)184:2<144::AID-PATH998>3.0.CO;2-J

DO - 10.1002/(SICI)1096-9896(199802)184:2<144::AID-PATH998>3.0.CO;2-J

M3 - Article

VL - 184

SP - 144

EP - 147

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -